New York Blood Center Unveils NYBC Ventures Blood Centers of America member, New York Blood Center, unveils its $50 million investment fund called NYBC Ventures.

Cell therapies made significant improvements in Q1 2023 Thus far in 2023: One cell therapy BLA approved by the FDA (1st expanded hematopoietic stem cell

Blood Centers of America member, LifeSouth Community Blood Centers, selected to provide CD34 cells to Dr. Abba C. Zubair of Mayo Clinic. Blood Centers of

Cord Blood Connect calls for abstracts to publish in STEM CELLS Translational Medicine. Whether your work focuses on preclinical studies, clinical trials, perinatal tissue banking

An interview of Dr. Michael Tees and Dr. Fred Locke offering clinician views on CAR-T A great interview of Dr. Michael Tees and Dr. Fred

An autologous tumor-infiltrating lymphocyte therapy for the treatment of advanced melanoma.